We are delighted to announce that the Second annual West Coast Sarcoma Conference will take place in Vancouver on April 12 & 13, 2019. The conference will be hosted at the Morris J Wosk Centre for Dialogue located in downtown Vancouver.
WCSC is unique in its inclusion of both pediatric and adult sarcoma specialists, with the objectives of ensuring best practices in sarcoma care and fostering collaboration across disciplines and geographic regions. We have succeeded in securing the participation of internationally renowned researchers and clinicians in the field of sarcoma. Dr. Robin Jones, Team Leader in Sarcoma Clinical Trials at The Institute of Cancer Research and Consultant Medical Oncologist at The Royal Marsden, UK, has agreed to be our keynote speaker. Dr. Jones is a specialist in the treatment of bone and soft tissue sarcomas, and focuses on developing novel therapies for these diseases.
We have put together an innovative program highlighting emerging techniques and current controversies in the diagnosis and management of sarcoma.
We look forward to welcoming you to Vancouver for the West Coast Sarcoma Conference!
West Coast Sarcoma Conference Chairs
Christine Simmons, MD, MSc, FRCPC, Vancouver, BC
Andrea MacNeill, MD, FRCSC, Vancouver, BC
Caroline Holloway, MD FRCPC, Vancouver, BC
Lee Cranmer, MD, PhD, FACP, Seattle WA
At the completion of the meeting, attendees should be able to:
1. Identify innovative molecular pathology techniques in use for sarcoma diagnosis.
2. Describe the current evidence with regards to adjuvant systemic therapy in the management of soft tissue sarcoma
3. Describe the multidisciplinary management of retroperitoneal sarcomas and identify the different treatments used to achieve disease control.
4. Describe recent advances in the management of bone sarcomas
5. Identify areas of developing research in the treatment of sarcoma
6. Describe the role of regional therapy in metastatic disease
7. Recognize the areas where collaboration could be improved in the palliation of young adults and adolescents (AYA).
8. Identify best practices for the diagnosis and management of Rhabdomyosarcoma
9. Apply current international guidelines with regards to centralization of care to the landscape of a geographically dispersed population